Biopharmaceuticals
Generics
FDA
News Release - August 18, 2009
Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
Source: Mylan
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.